Table 2.

Results of univariate and multivariate analyses showing prognostic factors for OS in patients with post-OLT HCC recurrence.

	Overall survival
	Univariate		Multivariate
	HR (95% CI)	P	HR (95% CI)	P
Age (<60 vs. ≥60)	0.93 (0.82–1.20)	0.65
Male Sex	0.75 (0.33–1.34)	0.61
AFP levels (≤400 vs. >400)	0.95 (0.77–2.19)	0.13	0.96 (0.84–2.34)	0.23
Liver cirrhosis	0.92 (0.62–1.82)	0.26
Tumor size (<5 cm vs. ≥5 cm)	0.63 (0.14–1.41)	0.48
BCLC stage	0.70 (0.16–0.98)	0.022	0.73 (0.27–0.99)	0.036
Sorafenib	2.94 (1.75–5.16)	0.007	2.26 (1.35–3.69)	0.01